DB05156ExperimentalSmall molecule
SL017 formulated as a topical gel, has been combined with a widely available light source for permanent removal of unwanted hair and for treatment of actinic keratosis.
- Mechanism
- Curator reviewed
SL017 is applied to human skin, allowed to penetrate into the target areas and is then illuminated with light of a specific wavelength in the red spectrum. Once illuminated, the non-toxic, SL017 is transformed into an extremely potent cytotoxic agent which can selectively destroy diseased tissue.
- Primary indication
- Investigated for use/treatment in acne, actinic keratosis, cancer/tumors (unspecified), keratoses, and skin infections/disorders.Curator reviewed
- Code names
- SL017
Which companies are running trials of SL017, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account